
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases
Nolwen L. Rey, Daniel W. Wesson, Patrik Brundin
Neurobiology of Disease (2016) Vol. 109, pp. 226-248
Open Access | Times Cited: 230
Nolwen L. Rey, Daniel W. Wesson, Patrik Brundin
Neurobiology of Disease (2016) Vol. 109, pp. 226-248
Open Access | Times Cited: 230
Showing 1-25 of 230 citing articles:
Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications
Marta Pajares, Ana I. Rojo, Gina Manda, et al.
Cells (2020) Vol. 9, Iss. 7, pp. 1687-1687
Open Access | Times Cited: 555
Marta Pajares, Ana I. Rojo, Gina Manda, et al.
Cells (2020) Vol. 9, Iss. 7, pp. 1687-1687
Open Access | Times Cited: 555
Brain-First versus Gut-First Parkinson’s Disease: A Hypothesis
Per Borghammer, Nathalie Van Den Berge
Journal of Parkinson s Disease (2019) Vol. 9, Iss. s2, pp. S281-S295
Open Access | Times Cited: 308
Per Borghammer, Nathalie Van Den Berge
Journal of Parkinson s Disease (2019) Vol. 9, Iss. s2, pp. S281-S295
Open Access | Times Cited: 308
Prying into the Prion Hypothesis for Parkinson's Disease
Patrik Brundin, Ronald Melki
Journal of Neuroscience (2017) Vol. 37, Iss. 41, pp. 9808-9818
Open Access | Times Cited: 245
Patrik Brundin, Ronald Melki
Journal of Neuroscience (2017) Vol. 37, Iss. 41, pp. 9808-9818
Open Access | Times Cited: 245
Therapeutic approaches to target alpha-synuclein pathology
Patrik Brundin, Kuldip D. Dave, Jeffrey H. Kordower
Experimental Neurology (2017) Vol. 298, pp. 225-235
Open Access | Times Cited: 217
Patrik Brundin, Kuldip D. Dave, Jeffrey H. Kordower
Experimental Neurology (2017) Vol. 298, pp. 225-235
Open Access | Times Cited: 217
α-Synuclein transfer between neurons and astrocytes indicates that astrocytes play a role in degradation rather than in spreading
Frida Loría, Jessica Vargas, Luc Bousset, et al.
Acta Neuropathologica (2017) Vol. 134, Iss. 5, pp. 789-808
Closed Access | Times Cited: 215
Frida Loría, Jessica Vargas, Luc Bousset, et al.
Acta Neuropathologica (2017) Vol. 134, Iss. 5, pp. 789-808
Closed Access | Times Cited: 215
Olfactory Dysfunction in Neurodegenerative Diseases
Concepció Marı́n, Dolores Vilas, Cristóbal Langdon, et al.
Current Allergy and Asthma Reports (2018) Vol. 18, Iss. 8
Closed Access | Times Cited: 208
Concepció Marı́n, Dolores Vilas, Cristóbal Langdon, et al.
Current Allergy and Asthma Reports (2018) Vol. 18, Iss. 8
Closed Access | Times Cited: 208
Spread of aggregates after olfactory bulb injection of α-synuclein fibrils is associated with early neuronal loss and is reduced long term
Nolwen L. Rey, Sonia George, Jennifer A. Steiner, et al.
Acta Neuropathologica (2017) Vol. 135, Iss. 1, pp. 65-83
Open Access | Times Cited: 179
Nolwen L. Rey, Sonia George, Jennifer A. Steiner, et al.
Acta Neuropathologica (2017) Vol. 135, Iss. 1, pp. 65-83
Open Access | Times Cited: 179
The concept of alpha-synuclein as a prion-like protein: ten years after
Jennifer A. Steiner, Emmanuel Quansah, Patrik Brundin
Cell and Tissue Research (2018) Vol. 373, Iss. 1, pp. 161-173
Open Access | Times Cited: 163
Jennifer A. Steiner, Emmanuel Quansah, Patrik Brundin
Cell and Tissue Research (2018) Vol. 373, Iss. 1, pp. 161-173
Open Access | Times Cited: 163
Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?
Javier Blesa, Guglielmo Foffani, Benjamin Dehay, et al.
Nature reviews. Neuroscience (2021) Vol. 23, Iss. 2, pp. 115-128
Closed Access | Times Cited: 157
Javier Blesa, Guglielmo Foffani, Benjamin Dehay, et al.
Nature reviews. Neuroscience (2021) Vol. 23, Iss. 2, pp. 115-128
Closed Access | Times Cited: 157
Impact of the COVID ‐19 Pandemic on Parkinson's Disease and Movement Disorders
Stella M. Papa, Patrik Brundin, Victor S.C. Fung, et al.
Movement Disorders (2020) Vol. 35, Iss. 5, pp. 711-715
Open Access | Times Cited: 155
Stella M. Papa, Patrik Brundin, Victor S.C. Fung, et al.
Movement Disorders (2020) Vol. 35, Iss. 5, pp. 711-715
Open Access | Times Cited: 155
Reverse engineering Lewy bodies: how far have we come and how far can we go?
Mohamed Bilal Fares, Somanath Jagannath, Hilal A. Lashuel
Nature reviews. Neuroscience (2021) Vol. 22, Iss. 2, pp. 111-131
Closed Access | Times Cited: 140
Mohamed Bilal Fares, Somanath Jagannath, Hilal A. Lashuel
Nature reviews. Neuroscience (2021) Vol. 22, Iss. 2, pp. 111-131
Closed Access | Times Cited: 140
Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder
Ambra Stefani, Álex Iranzo, Evi Holzknecht, et al.
Brain (2021) Vol. 144, Iss. 4, pp. 1118-1126
Open Access | Times Cited: 130
Ambra Stefani, Álex Iranzo, Evi Holzknecht, et al.
Brain (2021) Vol. 144, Iss. 4, pp. 1118-1126
Open Access | Times Cited: 130
Olfactory dysfunction in aging and neurodegenerative diseases
Xiuli Dan, Noah Wechter, Samuel H. Gray, et al.
Ageing Research Reviews (2021) Vol. 70, pp. 101416-101416
Open Access | Times Cited: 125
Xiuli Dan, Noah Wechter, Samuel H. Gray, et al.
Ageing Research Reviews (2021) Vol. 70, pp. 101416-101416
Open Access | Times Cited: 125
Neurons, Nose, and Neurodegenerative Diseases: Olfactory Function and Cognitive Impairment
Irene Fatuzzo, Giovanni Francesco Niccolini, Federica Zoccali, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2117-2117
Open Access | Times Cited: 47
Irene Fatuzzo, Giovanni Francesco Niccolini, Federica Zoccali, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2117-2117
Open Access | Times Cited: 47
Targeted Therapies for Parkinson's Disease: From Genetics to the Clinic
S. Pablo Sardi, Jesse M. Cedarbaum, Patrik Brundin
Movement Disorders (2018) Vol. 33, Iss. 5, pp. 684-696
Open Access | Times Cited: 156
S. Pablo Sardi, Jesse M. Cedarbaum, Patrik Brundin
Movement Disorders (2018) Vol. 33, Iss. 5, pp. 684-696
Open Access | Times Cited: 156
Outside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinson's Disease
Paulina Troncoso-Escudero, Alejandra V. Parra, Melissa Nassif, et al.
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 156
Paulina Troncoso-Escudero, Alejandra V. Parra, Melissa Nassif, et al.
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 156
Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology
Deidiane Elisa Ribeiro, Ágatha Oliveira‐Giacomelli, Talita Glaser, et al.
Molecular Psychiatry (2020) Vol. 26, Iss. 4, pp. 1044-1059
Open Access | Times Cited: 126
Deidiane Elisa Ribeiro, Ágatha Oliveira‐Giacomelli, Talita Glaser, et al.
Molecular Psychiatry (2020) Vol. 26, Iss. 4, pp. 1044-1059
Open Access | Times Cited: 126
How does parkinson's disease begin? Perspectives on neuroanatomical pathways, prions, and histology
Per Borghammer
Movement Disorders (2017) Vol. 33, Iss. 1, pp. 48-57
Closed Access | Times Cited: 124
Per Borghammer
Movement Disorders (2017) Vol. 33, Iss. 1, pp. 48-57
Closed Access | Times Cited: 124
CNS implications of COVID-19: a comprehensive review
Priyanka Nagu, Arun Parashar, Tapan Behl, et al.
Reviews in the Neurosciences (2020) Vol. 32, Iss. 2, pp. 219-234
Open Access | Times Cited: 123
Priyanka Nagu, Arun Parashar, Tapan Behl, et al.
Reviews in the Neurosciences (2020) Vol. 32, Iss. 2, pp. 219-234
Open Access | Times Cited: 123
Prion-Like Mechanisms in Parkinson’s Disease
Jiangnan Ma, Jing Gao, Jing Wang, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 117
Jiangnan Ma, Jing Gao, Jing Wang, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 117
The human olfactory system in two proteinopathies: Alzheimer’s and Parkinson’s diseases
Isabel Úbeda‐Bañón, Daniel Saiz‐Sánchez, Alicia Flores‐Cuadrado, et al.
Translational Neurodegeneration (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 96
Isabel Úbeda‐Bañón, Daniel Saiz‐Sánchez, Alicia Flores‐Cuadrado, et al.
Translational Neurodegeneration (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 96
Invited Review: From nose to gut – the role of the microbiome in neurological disease
Jack Bell, Jonathan I Spencer, Richard L. Yates, et al.
Neuropathology and Applied Neurobiology (2018) Vol. 45, Iss. 3, pp. 195-215
Closed Access | Times Cited: 94
Jack Bell, Jonathan I Spencer, Richard L. Yates, et al.
Neuropathology and Applied Neurobiology (2018) Vol. 45, Iss. 3, pp. 195-215
Closed Access | Times Cited: 94
Lipopolysaccharide animal models of Parkinson’s disease: Recent progress and relevance to clinical disease
Isaac Deng, Frances Corrigan, Guangxi Zhai, et al.
Brain Behavior & Immunity - Health (2020) Vol. 4, pp. 100060-100060
Open Access | Times Cited: 89
Isaac Deng, Frances Corrigan, Guangxi Zhai, et al.
Brain Behavior & Immunity - Health (2020) Vol. 4, pp. 100060-100060
Open Access | Times Cited: 89
A Self-Assembled α-Synuclein Nanoscavenger for Parkinson’s Disease
Jingyi Liu, Chao Liu, Jinfeng Zhang, et al.
ACS Nano (2020) Vol. 14, Iss. 2, pp. 1533-1549
Closed Access | Times Cited: 85
Jingyi Liu, Chao Liu, Jinfeng Zhang, et al.
ACS Nano (2020) Vol. 14, Iss. 2, pp. 1533-1549
Closed Access | Times Cited: 85
α-Synuclein fibrils subvert lysosome structure and function for the propagation of protein misfolding between cells through tunneling nanotubes
Aysegul Dilsizoglu Senol, Maura Samarani, Sylvie Syan, et al.
PLoS Biology (2021) Vol. 19, Iss. 7, pp. e3001287-e3001287
Open Access | Times Cited: 81
Aysegul Dilsizoglu Senol, Maura Samarani, Sylvie Syan, et al.
PLoS Biology (2021) Vol. 19, Iss. 7, pp. e3001287-e3001287
Open Access | Times Cited: 81